A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412].
Identifieur interne : 003A36 ( PubMed/Corpus ); précédent : 003A35; suivant : 003A37A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412].
Auteurs : Olivia Wilburn ; Paul Wilburn ; Stanley G. RocksonSource :
- BMC cancer [ 1471-2407 ] ; 2006.
English descriptors
- KwdEn :
- MESH :
- complications : Breast Neoplasms.
- diagnosis : Lymphedema.
- etiology : Lymphedema.
- instrumentation : Physical Therapy Modalities, Self Care.
- therapy : Lymphedema.
- Aged, Female, Humans, Massage, Middle Aged, Pilot Projects, Quality of Life, Treatment Outcome.
Abstract
Prospective investigations of complete decongestive lymphatic physiotherapy (CDPT), including manual lymphatic drainage (MLD), have validated the efficacy of these interventions for the initial reduction of edema and long-term maintenance of limb volume in lymphedema. However, CDPT demands substantial time and effort from patients to maintain these benefits; the treatments are not always well-accepted, and patients may suffer from a deterioration in quality-of-life or a time-dependent loss of initial treatment benefits. A new device designed for home use by the patient, the Flexitouch, has been developed to mechanically simulate MLD. We have undertaken a prospective, randomized, crossover study of the efficacy of the Flexitouch, when compared to massage, in the self-administered maintenance therapy of lymphedema.
DOI: 10.1186/1471-2407-6-84
PubMed: 16571129
Links to Exploration step
pubmed:16571129Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412].</title><author><name sortKey="Wilburn, Olivia" sort="Wilburn, Olivia" uniqKey="Wilburn O" first="Olivia" last="Wilburn">Olivia Wilburn</name><affiliation><nlm:affiliation>Stanford Center for Lymphatic and Venous Disorders, Stanford University School of Medicine, Falk Cardiovascular Research Center, Stanford, California 94305, USA. owilburn@gmail.com</nlm:affiliation></affiliation></author><author><name sortKey="Wilburn, Paul" sort="Wilburn, Paul" uniqKey="Wilburn P" first="Paul" last="Wilburn">Paul Wilburn</name></author><author><name sortKey="Rockson, Stanley G" sort="Rockson, Stanley G" uniqKey="Rockson S" first="Stanley G" last="Rockson">Stanley G. Rockson</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:16571129</idno><idno type="pmid">16571129</idno><idno type="doi">10.1186/1471-2407-6-84</idno><idno type="wicri:Area/PubMed/Corpus">003A36</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003A36</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412].</title><author><name sortKey="Wilburn, Olivia" sort="Wilburn, Olivia" uniqKey="Wilburn O" first="Olivia" last="Wilburn">Olivia Wilburn</name><affiliation><nlm:affiliation>Stanford Center for Lymphatic and Venous Disorders, Stanford University School of Medicine, Falk Cardiovascular Research Center, Stanford, California 94305, USA. owilburn@gmail.com</nlm:affiliation></affiliation></author><author><name sortKey="Wilburn, Paul" sort="Wilburn, Paul" uniqKey="Wilburn P" first="Paul" last="Wilburn">Paul Wilburn</name></author><author><name sortKey="Rockson, Stanley G" sort="Rockson, Stanley G" uniqKey="Rockson S" first="Stanley G" last="Rockson">Stanley G. Rockson</name></author></analytic><series><title level="j">BMC cancer</title><idno type="eISSN">1471-2407</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Breast Neoplasms (complications)</term><term>Female</term><term>Humans</term><term>Lymphedema (diagnosis)</term><term>Lymphedema (etiology)</term><term>Lymphedema (therapy)</term><term>Massage</term><term>Middle Aged</term><term>Physical Therapy Modalities (instrumentation)</term><term>Pilot Projects</term><term>Quality of Life</term><term>Self Care (instrumentation)</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Physical Therapy Modalities</term><term>Self Care</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Humans</term><term>Massage</term><term>Middle Aged</term><term>Pilot Projects</term><term>Quality of Life</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Prospective investigations of complete decongestive lymphatic physiotherapy (CDPT), including manual lymphatic drainage (MLD), have validated the efficacy of these interventions for the initial reduction of edema and long-term maintenance of limb volume in lymphedema. However, CDPT demands substantial time and effort from patients to maintain these benefits; the treatments are not always well-accepted, and patients may suffer from a deterioration in quality-of-life or a time-dependent loss of initial treatment benefits. A new device designed for home use by the patient, the Flexitouch, has been developed to mechanically simulate MLD. We have undertaken a prospective, randomized, crossover study of the efficacy of the Flexitouch, when compared to massage, in the self-administered maintenance therapy of lymphedema.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16571129</PMID><DateCreated><Year>2006</Year><Month>04</Month><Day>20</Day></DateCreated><DateCompleted><Year>2006</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2407</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2006</Year><Month>Mar</Month><Day>29</Day></PubDate></JournalIssue><Title>BMC cancer</Title><ISOAbbreviation>BMC Cancer</ISOAbbreviation></Journal><ArticleTitle>A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412].</ArticleTitle><Pagination><MedlinePgn>84</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Prospective investigations of complete decongestive lymphatic physiotherapy (CDPT), including manual lymphatic drainage (MLD), have validated the efficacy of these interventions for the initial reduction of edema and long-term maintenance of limb volume in lymphedema. However, CDPT demands substantial time and effort from patients to maintain these benefits; the treatments are not always well-accepted, and patients may suffer from a deterioration in quality-of-life or a time-dependent loss of initial treatment benefits. A new device designed for home use by the patient, the Flexitouch, has been developed to mechanically simulate MLD. We have undertaken a prospective, randomized, crossover study of the efficacy of the Flexitouch, when compared to massage, in the self-administered maintenance therapy of lymphedema.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective, randomized, crossover study of maintenance therapy was performed in 10 patients with unilateral breast cancer-associated lymphedema of the arm. Each observation phase included self-administered treatment with the Flexitouch or massage, 1 hour daily for 14 days, respectively, followed by crossover to the alternate treatment phase. Each treatment phase was preceded by a 1 week treatment washout, with use of garment only. The sequence of treatment was randomly assigned. The potential impact of treatment modality on quality of life was assessed with serial administration of the SF-36.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Statistical analysis disclosed that the order of treatment had no outcome influence, permitting 10 comparisons within each treatment group. Post-treatment arm volume reduced significantly after the Flexitouch, but not after self-administered massage. The patients' mean weight decreased significantly with Flexitouch use, but not with massage. The Flexitouch device was apparently well-tolerated and accepted by patients. Serial SF-36 administration showed no deterioration in physical or psychosocial scores compared to baseline measurements; there were no statistical differences in scores when the two treatment modalities were compared.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This short-term prospective evaluation of the Flexitouch suggests that the device may provide better maintenance edema control than self-adiminstered massage in breast cancer-associated lymphedema. The apparent ease of use and reliability of response to the device suggest that further broad-scale testing is warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wilburn</LastName><ForeName>Olivia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Stanford Center for Lymphatic and Venous Disorders, Stanford University School of Medicine, Falk Cardiovascular Research Center, Stanford, California 94305, USA. owilburn@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilburn</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Rockson</LastName><ForeName>Stanley G</ForeName><Initials>SG</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ISRCTN</DataBankName><AccessionNumberList><AccessionNumber>ISRCTN76522412</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2006</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Cancer</MedlineTA><NlmUniqueID>100967800</NlmUniqueID><ISSNLinking>1471-2407</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2776-81</RefSource><PMID Version="1">9874397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast J. 2000 Nov;6(6):373-378</RefSource><PMID Version="1">11348395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Australas J Dermatol. 1992;33(2):61-8</RefSource><PMID Version="1">1294054</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2001 May;37(8):991-9</RefSource><PMID Version="1">11334724</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med. 2000 Sep;109(4):296-300</RefSource><PMID Version="1">10996580</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Surg. 1998 Apr;133(4):452-8</RefSource><PMID Version="1">9565129</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vasc Med. 1998;3(2):145-56</RefSource><PMID Version="1">9796078</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med. 2001 Mar;110(4):288-95</RefSource><PMID Version="1">11239847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2000 Sep-Oct;50(5):292-307; quiz 308-11</RefSource><PMID Version="1">11075239</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2004 Sep;37(3):127-33</RefSource><PMID Version="1">15560108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Plast Surg. 1989 Jun;22(6):505-15</RefSource><PMID Version="1">2751222</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1993 Dec 1;72(11):3248-52</RefSource><PMID Version="1">8242549</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast J. 2004 Sep-Oct;10(5):405-11</RefSource><PMID Version="1">15327493</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vasc Med. 1997 Nov;2(4):321-6</RefSource><PMID Version="1">9575606</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer Care (Engl). 1995 Mar;4(1):11-6</RefSource><PMID Version="1">7620649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 1999 Mar;177(3):184-7; discussion 188</RefSource><PMID Version="1">10219851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Dermatol. 1995 Sep-Oct;13(5):433-44</RefSource><PMID Version="1">8665454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 1997 Jun;24(5):875-82</RefSource><PMID Version="1">9201739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2004 Jul;86(2):95-106</RefSource><PMID Version="1">15319562</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Emerg Infect Dis. 2004 Nov;10(11):1938-46</RefSource><PMID Version="1">15550203</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2001 Sep 15;92(6):1368-77</RefSource><PMID Version="1">11745212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pain Symptom Manage. 1993 May;8(4):226-33</RefSource><PMID Version="1">7963764</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surgery. 1999 Jul;126(1):1-4</RefSource><PMID Version="1">10418584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2002 Dec 1;95(11):2260-7</RefSource><PMID Version="1">12436430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2882-5</RefSource><PMID Version="1">9874417</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Skin Wound Care. 2004 May;17(4 Pt 1):174-8; quiz 179-80</RefSource><PMID Version="1">15360026</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008405" MajorTopicYN="N">Massage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026741" MajorTopicYN="N">Physical Therapy Modalities</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012648" MajorTopicYN="N">Self Care</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC1440867</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year><Month>11</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>03</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>3</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>5</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>3</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16571129</ArticleId><ArticleId IdType="pii">1471-2407-6-84</ArticleId><ArticleId IdType="doi">10.1186/1471-2407-6-84</ArticleId><ArticleId IdType="pmc">PMC1440867</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A36 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003A36 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:16571129
|texte= A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:16571129" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |